| Modern approaches to the diagnosis and treatment of chemotherapy toxicity in patients with breast cancer LA Syvak, HO Hubareva, KS Filonenko, NM Majdanevych, OM Aleksyk, ... Likars' ka Sprava, 3-15, 2015 | 4 | 2015 |
| T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2-RAFTING … A Gallamini, M Picardi, K Filonenko, M Gotti, JN Céspedes, A Rossi, ... HemaSphere 6, 10-11, 2022 | 3 | 2022 |
| 18F-FDG PET/CT cannot substitute endoscopy in the staging of gastrointestinal involvement in mantle cell lymphoma. A retrospective multi-center cohort analysis T Skrypets, C Ferrari, L Nassi, G Margiotta Casaluci, B Puccini, L Mannelli, ... Journal of Personalized Medicine 11 (2), 123, 2021 | 3 | 2021 |
| The predictive value of immunohistochemical expression of Bcl-2, Bcl-6, MUM1, CD10 and CD30 in patients with diffuse large cell lymphoma I Kryachok, AV Martynchyk, K Filonenko, AN Grabovoy, SA Antoniuk, ... Annals of Oncology 27, vi318, 2016 | 2 | 2016 |
| Comparison of the efficiency of peripheral blood stem cell apheresis on the blood cell separators K Filonenko, V Zarutska, A Martynchyk, Y Kushchevyi, Y Stepanishyna, ... Klin Onkol 35 (6), 448-453, 2022 | 1 | 2022 |
| Subtypes of malignant lymphomas in Ukraine, according to 2016 WHO Classification. Preliminary report of the Ukrainian Lymphoma Registry T Skrypets, Y Stepanishyna, GR Galli, M Manni, A Hubareva, I Tytorenko, ... Hematological Oncology 39, 2021 | 1 | 2021 |
| Can18F-FDG PET/CT overcome endoscopy in the staging of gastrointestinal involvement in Mantle Cell Lymphoma? A retrospective multi-center cohort analysis. T Skrypets, L Nassi, GM Casaluci, B Puccini, L Mannelli, S Kovalchuk, ... | 1 | 2020 |
| Implementation and evaluation of the first global blood & marrow transplantation (globalbmt) training program at the university of illinois at chicago (UIC) O Olowoselu, A Amaru, K Filonenko, R Mbiine, S Tuladhar, D Rondelli Biology of Blood and Marrow Transplantation 25 (3), S322-S323, 2019 | 1 | 2019 |
| The role of indoleamine 2, 3-dioxygenase expression in diffuse large B-cell lymphoma prognosis I Kryachok, T Skrypets, O Novosad, N Khranovska, O Skachkova, ... Annals of Oncology 27, vi318, 2016 | 1 | 2016 |
| Сучасні погляди на діагностику та лікування токсичних проявів хіміотерапії у хворих на злоякісні пухлини грудної залози LA Syvak, HO Hubareva, KS Filonenko, NM Majdanevych, OM Aleksyk, ... Likars' ka sprava, 3-15, 2015 | 1 | 2015 |
| Efficiency therapy with rituximab in patients with non-Hodgkin's lymphomas IA Kriachok, KS Filonenko, GO Gubareva, IB Tytorenko, OI Novosad, ... Likars' ka Sprava, 117-121, 2011 | 1 | 2011 |
| Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019–2021 Y Stepanishyna, M Manni, M Civallero, N Shokun, T Skrypets, A Burtna, ... British Journal of Haematology, 2024 | | 2024 |
| AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR MARGINAL ZONE LYMPHOMAS-MULTICENTER ANALYSIS BY THE POLISH LYMPHOMA RESEARCH GROUP J Drozd-Sokolowska, M Sobczyk-Kruszelnicka, A Kopinska, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 450-451, 2023 | | 2023 |
| EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTINE AS A SALVAGE TREATMENT BEFORE AUTOLOGOUS SCT IN PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA-UKRAINIAN EXPERIENCE K Filonenko, Y Stepanishyna, Y Kushchevyi, A Martynchyk BONE MARROW TRANSPLANTATION 58 (SUPP 1), 460-461, 2023 | | 2023 |
| P1181: REAL-LIFE TREATMENT APPROACHES AND THERAPY RESULTS IN THE PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: POLISH-UKRAINIAN EXPERIENCE K Filonenko, A Szymańska, Y Stepanishyna, N Shokun, T Skrypets, ... HemaSphere 7 (S3), e8467534, 2023 | | 2023 |
| THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INADEQUATE RESPONSE TO CHEMOTHERAPY. THE PRELIMINARY EXPERIENCE FROM THE RAFTING TRIAL K Filonenko, E Domingo‐Domenech, M Gotti, J Núñez, A Rambaldi, ... Hematological Oncology 41, 674-675, 2023 | | 2023 |
| Baseline‐PET derived metrics are the most relevant factors for risk stratification in early‐stage nonbulky HL: preliminary results of the RAFTING trial JM Zaucha, M Picardi, M Kurlapski, C Patti, E Domingo‐Domenech, ... Hematological Oncology 41, 350-351, 2023 | | 2023 |
| LANGERHANS CELL HISTIOCYTOSIS (LCH): UKRAINIAN PROSPECTIVE STUDY IN A REAL-LIFE COHORT, UPDATED RESULT O Novosad, I Kriachok, I Pastushenko, O Gorbach, O Skachkova, ... PEDIATRIC BLOOD & CANCER 70, S35-S35, 2023 | | 2023 |
| PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP K Filonenko, I Kriachok, A Martynchyk, I Titorenko, Y Stepanishyna, ... HemaSphere 6, 1985-1986, 2022 | | 2022 |
| PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS I Tytorenko, I Kryachоk, O Alexik, T Kadnikova, A Martynchik, O Novosad, ... HemaSphere 6, 2153-2154, 2022 | | 2022 |
